Page last updated: 2024-08-16

risperidone and raclopride

risperidone has been researched along with raclopride in 40 studies

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (37.50)	18.2507
2000's	16 (40.00)	29.6817
2010's	9 (22.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bervoets, K; Brocco, M; Dacquet, C; Girardon, S; Gobert, A; Millan, MJ; Newman-Tancredi, A; Peglion, JL; Rivet, JM; Vian, J	1
Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L	1
Topliss, JG; Yoshida, F	1
Eriksson, B; Eriksson, L; Farde, L; Halldin, C; Nyberg, S	1
Conway, PC; Corbett, R; Dunn, RW; Hartman, H; Helsley, GC; Kerman, LL; Strupczewski, JT; Woods, AT	1
Fukuda, T; Futamura, T; Haga, K; Ohashi, Y; Takahashi, Y; Yano, K	1
Hertel, P; Iurlo, M; Nomikos, GG; Svensson, TH	1
Navas, F; Norman, MH; Rigdon, GC; Thompson, JB	1
Hertel, P; Nomikos, GG; Svensson, TH	1
Kapur, S; Remington, G; Zipursky, R	1
Cherkerzian, S; Cohen, BM; Ennulat, DJ; Froimowitz, MP; Konieczna, H; Wan, W	1
Fletcher, PJ	1
Kapur, S; Remington, G; Zipursky, RB	1
Adler, CM; Breier, A; Elman, I; Malhotra, AK; Pickar, D; Su, TP; Weisenfeld, NI	1
Eriksson, B; Farde, L; Halldin, C; Nyberg, S; Oxenstierna, G	1
Carboni, E; Di Chiara, G; Rolando, MT; Silvagni, A	1
McCallum, SE; Porter, JH; Vann, RE; Varvel, SA	1
Aguilar, MA; Broseta, I; Miñarro, J; Rodríguez-Arias, M	1
Antoniou, K; Bekris, S; Papadopoulou-Daifoti, Z; Rimikis, M; Saranti, M; Stathis, P	1
Agid, O; Houle, S; Hussain, T; Kapur, S; Remington, G; Tauscher, J; Verhoeff, NP; Wilson, AA; Zipursky, RB	1
Burris, KD; Kikuchi, T; Miwa, T; Mori, T; Stark, A; Tadori, Y; Tottori, K	1
Kapur, S; Labelle, A; Mamo, D; Mann, S; Mannaert, E; Reiss, J; Remington, G; Shammi, C	1
Bastianetto, S; Danik, M; Mennicken, F; Quirion, R; Williams, S	1
Bedi, KS; Bryan-Lluka, LJ; Catts, SV; Catts, VS; Naiker, DV	1
Agid, O; Graff, A; Kapur, S; Mamo, DC; Mizrahi, R; Rusjan, P; Zipursky, RB	1
Brennum, LT; Kreilgaard, M; Olsen, CK	1
Graff-Guerrero, A; Mamo, DC; Mulsant, BH; Pollock, BG; Uchida, H	1
Graff-Guerrero, A; Kapur, S; Mamo, DC; Mulsant, BH; Pollock, BG; Uchida, H	1
Bjelica, A; Rajakumar, N; Rushlow, WJ; Seah, C; Sutton, LP	1
Barsoum, P; Graff-Guerrero, A; Houle, S; Kapur, S; Mamo, D; Marcon, H; Mizrahi, R; Rusjan, P; Shammi, CM; Wilson, AA	1
Egerod, KL; Holst, B; Husum, H; Mellerup, E; Secher, A	1
Arakawa, R; Ito, H; Kodaka, F; Miyoshi, M; Okumura, M; Otsuka, T; Suhara, T; Takahashi, H; Takano, H	1
Arakawa, R; Farde, L; Halldin, C; Ito, H; Kodaka, F; Miyoshi, M; Nakayama, K; Okumura, M; Otsuka, T; Suhara, T; Takahashi, H; Takano, H	1
Arenovich, T; Graff-Guerrero, A; Mamo, DC; Mulsant, BH; Pollock, BG; Rajji, TK; Suzuki, T; Uchida, H	1
De Luca, MA; Di Chiara, G; Perra, V; Serra, GP; Tanda, G; Valentini, V	1
Caravaggio, F; Gerretsen, P; Graff-Guerrero, A; Mamo, DC; Mar, W; Mulsant, BH; Nakajima, S; Pollock, BG; Rajji, TK; Suzuki, T; Uchida, H	2
Bies, RR; Caravaggio, F; Gerretsen, P; Graff-Guerrero, A; Mamo, DC; Mar, W; Mulsant, BH; Nakajima, S; Plitman, E; Pollock, BG; Suzuki, T; Uchida, H	1
Caravaggio, F; Chung, JK; Gerretsen, P; Graff-Guerrero, A; Iwata, Y; Mamo, DC; Mar, W; Mulsant, BH; Nakajima, S; Plitman, E; Pollock, BG; Rajji, TK; Suzuki, T; Uchida, H	1
Arnold, JC; Boucher, AA; Brzozowska, NI; Callaghan, PD; de Tonnerre, EJ; Kuligowski, M; Li, KM; Wang, XS; Wong, A	1

Trials

8 trial(s) available for risperidone and raclopride

Article	Year
5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology, 1993, Volume: 110, Issue:3 Topics: Adult; Antipsychotic Agents; Brain Chemistry; Cerebellum; Cerebral Cortex; Dopamine Antagonists; Humans; Isoxazoles; Male; Piperidines; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Tomography, Emission-Computed	1993
Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 20, Issue:4 Topics: Adult; Amphetamine; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neostriatum; Psychotic Disorders; Raclopride; Risperidone; Salicylamides; Tomography, Emission-Computed	1999
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. The American journal of psychiatry, 1999, Volume: 156, Issue:6 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Psychiatric Status Rating Scales; Raclopride; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Schizophrenia; Schizophrenic Psychology; Spiperone; Tomography, Emission-Computed; Treatment Outcome	1999
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. The American journal of psychiatry, 2007, Volume: 164, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Corpus Striatum; Female; Humans; Male; Middle Aged; Olanzapine; Raclopride; Radionuclide Imaging; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology	2007
The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO. Archives of general psychiatry, 2009, Volume: 66, Issue:6 Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzodiazepines; Benzothiazoles; Binding, Competitive; Carbon Radioisotopes; Caudate Nucleus; Clozapine; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Female; Globus Pallidus; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Olanzapine; Oxazines; Positron-Emission Tomography; Pramipexole; Putamen; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia	2009
Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine. The international journal of neuropsychopharmacology, 2011, Volume: 14, Issue:1 Topics: Adult; Apomorphine; Brain; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Ligands; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Risperidone; Schizophrenia; Young Adult	2011
Therapeutic window for striatal dopamine D(2/3) receptor occupancy in older patients with schizophrenia: a pilot PET study. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:10 Topics: Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Functional Neuroimaging; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Putamen; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia	2014
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia. The Journal of clinical psychiatry, 2016, Volume: 77, Issue:12 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Corpus Striatum; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Prolactin; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia	2016

Other Studies

32 other study(ies) available for risperidone and raclopride

Article	Year
Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:2 Topics: 2-Naphthylamine; Animals; Body Temperature Regulation; Catalepsy; CHO Cells; Cricetinae; Dopamine Antagonists; Furans; Humans; Male; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D2; Recombinant Proteins; Stereoisomerism	1995
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study. European journal of pharmacology, 1998, Aug-21, Volume: 355, Issue:2-3 Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes	1998
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacology, biochemistry, and behavior, 1993, Volume: 45, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Catalepsy; Chlorpromazine; Clozapine; Diazepam; Haloperidol; Isoxazoles; Male; Mice; Mice, Inbred Strains; Piperidines; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Social Behavior	1993
[The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 107, Issue:5 Topics: Antipsychotic Agents; Benzazepines; Cell Line; Clozapine; Haloperidol; Humans; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Dopamine D5; Risperidone; Salicylamides; Spiperone	1996
Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology, 1996, Volume: 124, Issue:1-2 Topics: Animals; Antipsychotic Agents; Brain; Cerebral Cortex; Clozapine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Male; Microdialysis; Nucleus Accumbens; Raclopride; Rats; Rats, Wistar; Risperidone; Salicylamides; Serotonin; Time Factors	1996
Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents. Journal of medicinal chemistry, 1996, Nov-22, Volume: 39, Issue:24 Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Clozapine; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Piperazines; Raclopride; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Salicylamides; Thiazoles	1996
Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine. British journal of pharmacology, 1997, Volume: 122, Issue:8 Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Hydroxyindoleacetic Acid; Idazoxan; Male; Piperazines; Prazosin; Pyridines; Raclopride; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Risperidone; Salicylamides; Serotonin; Serotonin Antagonists	1997
The relationship between risperidone plasma levels and dopamine D2 occupancy: a positron emission tomographic study. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1 Topics: Antipsychotic Agents; Carbon Radioisotopes; Dopamine Antagonists; Humans; Raclopride; Receptors, Dopamine D2; Risperidone; Salicylamides; Schizophrenia; Tomography, Emission-Computed	1998
Activation of midline thalamic nuclei by antipsychotic drugs. Psychopharmacology, 1998, Volume: 135, Issue:1 Topics: Animals; Antipsychotic Agents; Brain; Haloperidol; Male; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Salicylamides; Thalamic Nuclei; Thioridazine	1998
A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine. Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:1 Topics: Animals; Behavior, Animal; Dextroamphetamine; Dopamine Antagonists; Injections, Intravenous; Male; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin; Reinforcement Schedule; Risperidone; Ritanserin; Salicylamides; Self Administration; Serotonin Antagonists	1998
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. The American journal of psychiatry, 1999, Volume: 156, Issue:2 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Clozapine; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Schizophrenia; Tomography, Emission-Computed	1999
Stimulation of dopamine release in the bed nucleus of stria terminalis. A trait of atypical antipsychotics? Annals of the New York Academy of Sciences, 1999, Jun-29, Volume: 877 Topics: Amygdala; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine; Haloperidol; Indoles; Male; Olanzapine; Pirenzepine; Pyridines; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Salicylamides; Thalamus	1999
The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats. Psychopharmacology, 2000, Volume: 148, Issue:3 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Discrimination Learning; Generalization, Psychological; Haloperidol; Male; Olanzapine; Pirenzepine; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Ritanserin; Scopolamine	2000
Lack of specific effects of selective D(1) and D(2) dopamine antagonists vs. risperidone on morphine-induced hyperactivity. Pharmacology, biochemistry, and behavior, 2000, Volume: 66, Issue:1 Topics: Animals; Benzazepines; Catalepsy; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Male; Mice; Morphine; Motor Activity; Narcotics; Raclopride; Receptors, Dopamine D1; Risperidone	2000
The effects of antipsychotic drugs on serotonergic activity in the rat hippocampus. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:5 Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Haloperidol; Hippocampus; Hydroxyindoleacetic Acid; Ketanserin; Male; Raclopride; Rats; Rats, Wistar; Risperidone; Serotonin	2000
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. The American journal of psychiatry, 2004, Volume: 161, Issue:9 Topics: Adolescent; Adult; Antipsychotic Agents; Benzazepines; Benzodiazepines; Carbon Radioisotopes; Clozapine; Corpus Striatum; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed; Treatment Outcome	2004
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic. European journal of pharmacology, 2005, May-16, Volume: 515, Issue:1-3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Lisuride; Piperazines; Piperidines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Risperidone; Transfection; Tritium	2005
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone. The American journal of psychiatry, 2006, Volume: 163, Issue:3 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Corpus Striatum; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Positron-Emission Tomography; Prolactin; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia	2006
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. BMC neuroscience, 2006, Mar-30, Volume: 7 Topics: Animals; Anisoles; Antipsychotic Agents; Benzazepines; Butaclamol; Caspase Inhibitors; Cell Death; Cells, Cultured; Chlorpromazine; Clozapine; Domperidone; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ginkgo biloba; Haloperidol; Hippocampus; Indans; Isoxazoles; Neurons; Neuroprotective Agents; Peptides; Piperidines; Plant Extracts; Propylamines; Raclopride; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Remoxipride; Risperidone; Sulpiride	2006
Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat. European journal of pharmacology, 2006, Jul-01, Volume: 540, Issue:1-3 Topics: Algorithms; Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Cerebellum; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Male; Olanzapine; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; Risperidone; Tritium	2006
Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics. European journal of pharmacology, 2008, Apr-28, Volume: 584, Issue:2-3 Topics: Administration, Oral; Animals; Antipsychotic Agents; Basal Ganglia; Behavior, Animal; Benzodiazepines; Binding, Competitive; Clozapine; Conditioning, Psychological; Dopamine Antagonists; Haloperidol; Imidazoles; Indoles; Injections, Subcutaneous; Male; Models, Biological; Olanzapine; Protein Binding; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Reproducibility of Results; Risperidone	2008
Long-term stability of measuring D(2) receptors in schizophrenia patients treated with antipsychotics. Schizophrenia research, 2009, Volume: 109, Issue:1-3 Topics: Aged; Antipsychotic Agents; Brain; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia	2009
Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2009, Volume: 17, Issue:3 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Case-Control Studies; Cross-Sectional Studies; Dopamine Antagonists; Female; Humans; Isoxazoles; Male; Middle Aged; Ontario; Paliperidone Palmitate; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia; Treatment Outcome	2009
Antipsychotics affect multiple calcium calmodulin dependent proteins. Neuroscience, 2009, Jul-07, Volume: 161, Issue:3 Topics: Animals; Antipsychotic Agents; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Clozapine; Corpus Striatum; Dopamine Antagonists; Haloperidol; Male; Psychotropic Drugs; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; RNA, Messenger	2009
Risperidone treatment increases CB1 receptor binding in rat brain. Neuroendocrinology, 2010, Volume: 91, Issue:2 Topics: Adiponectin; Animals; Antipsychotic Agents; Brain; Cyclohexanols; Dopamine Antagonists; Eating; Ghrelin; Male; Motor Activity; Neuropeptide Y; Pro-Opiomelanocortin; Prolactin; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Receptors, Ghrelin; Risperidone; RNA, Messenger; Tritium; Weight Gain	2010
Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission? The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Oct-28, Volume: 29, Issue:43 Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Humans; Isoxazoles; Levodopa; Male; Paliperidone Palmitate; Positron-Emission Tomography; Putamen; Pyrimidines; Raclopride; Receptors, Dopamine D2; Rest; Risperidone; Synaptic Transmission; Young Adult	2009
A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics. Psychopharmacology, 2015, Volume: 232, Issue:8 Topics: Administration, Intravenous; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Dopamine; Haloperidol; Male; Microdialysis; Nucleus Accumbens; Prefrontal Cortex; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Time Factors	2015
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study. JAMA psychiatry, 2015, Volume: 72, Issue:9 Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Brain; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Neostriatum; Olanzapine; Positron-Emission Tomography; Prolactin; Prospective Studies; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia; Treatment Outcome	2015
Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial. Schizophrenia bulletin, 2016, Volume: 42, Issue:1 Topics: Aged; Antipsychotic Agents; Benzodiazepines; Brain; Carbon Radioisotopes; Chromatography, Liquid; Female; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Positron-Emission Tomography; Prospective Studies; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia; Tandem Mass Spectrometry	2016
Cognition and Dopamine D The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2017, Volume: 25, Issue:1 Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cognitive Dysfunction; Corpus Striatum; Female; Humans; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Psychotic Disorders; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia	2017
The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017, Volume: 42, Issue:11 Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Clozapine; Dose-Response Relationship, Drug; Dronabinol; Gene Expression Regulation; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Binding; Proto-Oncogene Proteins c-fos; Raclopride; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Reflex, Startle; Risperidone; Time Factors; Tritium	2017